Medicare Enrolled

Dr. Stephanie Vanderveldt, MD

Ophthalmology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
1100 JOHNSON FERRY RD NE, Atlanta, GA 30342
4042559096
In practice since 2006 (20 years)
NPI: 1538109160 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vanderveldt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanderveldt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vanderveldt

Dr. Stephanie Vanderveldt is an ophthalmology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vanderveldt performed 70,688 Medicare services across 4,321 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vanderveldt received a total of $440,312 from 24 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vanderveldt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in GA $440,312 industry payments

Medicare Practice Summary

Medicare Utilization ↗
70,688
Medicare services
Top 0% in GA for ophthalmology
4,321
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,534 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
54,782 $29 $108
Injection, ranibizumab, 0.1 mg 5,029 $179 $1,082
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,742 $31 $129
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
2,452 $99 $1,497
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,669 $91 $255
Aflibercept eye injection (Eylea) 1,344 $686 $2,100
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
421 $120 $292
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
315 $156 $372
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
224 $67 $175
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
205 $54 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
180 $121 $400
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
173 $23 $200
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
72 $31 $361
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
29 $1,743 $3,678
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
22 $103 $350
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
15 $181 $1,940
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
14 $892 $5,783
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$440,312
Total received (2018-2024)
Avg $62,902/year across 7 years
Top 0% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$194,440 (44.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$128,913 (29.3%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$103,590 (23.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,900 (2.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,469 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,037
2023
$19,677
2022
$33,047
2021
$208,077
2020
$35,088
2019
$67,264
2018
$59,122

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alimera Sciences, Inc.
$9,071
Genentech USA, Inc.
$8,217
Apellis Pharmaceuticals, Inc.
$207
Astellas Pharma US Inc
$200
Biogen, Inc.
$137
Regeneron Healthcare Solutions, Inc.
$75
ABBVIE INC.
$72
Sandoz Inc.
$39
Coherus Biosciences Inc.
$18
Top 3 companies account for 97.0% of 2024 payments
All-time payments by company (2018-2024) ›
US Retina LLC
$298,030
Genentech USA, Inc.
$92,393
Alimera Sciences, Inc.
$16,530
Allergan Inc.
$12,591
Novartis Pharmaceuticals Corporation
$10,235
Apellis Pharmaceuticals, Inc.
$3,750
Regeneron Pharmaceuticals, Inc.
$2,780
Regeneron Healthcare Solutions, Inc.
$1,031
Alcon Vision LLC
$550
EyePoint Pharmaceuticals US, Inc.
$414
Astellas Pharma US Inc
$348
Biogen, Inc.
$323
Carl Zeiss Meditec USA, Inc.
$268
Genentech, Inc.
$181
Sight Sciences, Inc.
$147
Allergan, Inc.
$134
Coherus Biosciences Inc.
$133
Shire North American Group Inc
$116
ABBVIE INC.
$103
Spark Therapeutics, Inc.
$96
AbbVie Inc.
$50
Sandoz Inc.
$39
Bausch & Lomb, a division of Bausch Health US, LLC
$36
Mallinckrodt LLC
$35
Top 3 companies account for 92.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BYOOVIZ · CIRRUS HD-OCT · CLARUS 700 · COMBIGAN · Cimerli · Constellation · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Izervay · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · Luxor · NGENUITY · OMNI SURGICAL SYSTEM · OZURDEX · SIMBRINZA · SUSVIMO · SYFOVRE · Susvimo · Syfovre · VABYSMO · VISULAS 532s · Vabysmo · XIIDRA · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 0% for ophthalmology in GA.

Looking for an ophthalmology specialist in Atlanta?
Compare ophthalmologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
263
Per 100K population
24.6
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vanderveldt is a mixed practice specialist, with above-average Medicare volume (top 0% in GA), with mixed engagement industry engagement in the top 0% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vanderveldt experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Vanderveldt performed 54,782 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vanderveldt receive payments from pharmaceutical companies?
Yes. Dr. Vanderveldt received a total of $440,312 from 24 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanderveldt's costs compare to other ophthalmologists in Atlanta?
Dr. Vanderveldt's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanderveldt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →